<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-19T04:52:58Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/10692" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/10692</identifier><datestamp>2026-10-18T21:13:13Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Nobiletin reduces 5-FU-induced lung injury with antioxidative, anti-inflammatory and anti-apoptotic activities</dc:title><dc:creator>Atila Uslu, Gözde</dc:creator><dc:creator>Uslu, Hamit</dc:creator><dc:creator>Çoban, Taha Abdulkadir</dc:creator><dc:creator>Özkaraca, Mustafa</dc:creator><dc:creator>Mendil, Ali Sefa</dc:creator><dc:creator>Aygörmez, Serpil</dc:creator><dc:subject>5-Fluorouracil</dc:subject><dc:subject>Apoptosis</dc:subject><dc:subject>Inflammation</dc:subject><dc:subject>Lung damage</dc:subject><dc:subject>Nobiletin</dc:subject><dc:subject>Oxidative stress</dc:subject><dc:subject>Animals</dc:subject><dc:subject>Anti-Inflammatory Agents</dc:subject><dc:subject>Antimetabolites, Antineoplastic</dc:subject><dc:subject>Antioxidants</dc:subject><dc:subject>Flavones</dc:subject><dc:subject>Fluorouracil</dc:subject><dc:subject>Interleukin-1beta</dc:subject><dc:subject>Lung</dc:subject><dc:subject>Lung Injury</dc:subject><dc:subject>Male</dc:subject><dc:subject>NF-kappa B</dc:subject><dc:subject>Rats, Wistar</dc:subject><dc:subject>caspase 3</dc:subject><dc:subject>glutathione</dc:subject><dc:subject>interleukin 1beta</dc:subject><dc:subject>malonaldehyde</dc:subject><dc:subject>protein Bax</dc:subject><dc:subject>protein bcl 2</dc:subject><dc:subject>sodium chloride</dc:subject><dc:subject>antiinflammatory agent</dc:subject><dc:subject>antineoplastic antimetabolite</dc:subject><dc:subject>antioxidant</dc:subject><dc:subject>flavone derivative</dc:subject><dc:subject>immunoglobulin enhancer binding protein</dc:subject><dc:description>Like other chemotherapeutic agents, 5-fluorouracil (5-FU) targets cancerous cells, but it also causes many unwanted side effects on healthy tissues and cells. Based on the undesirable effects of 5-FU, the aim of this study was to determine how 5-FU affects lung tissue and whether nobiletin has any protective effect. The study consisted of negative control, Nobiletin, 5-FU and Nobiletin + 5-FU groups. Nobiletin and Nobiletin + 5-FU groups received 10 mg/kg Nobiletin i.g. for 7 days. On day 8, 100 mg/kg 5-FU was administered i.p. to 5-FU and Nobiletin + 5-FU groups. Biochemical and immunohistochemical analyses were performed on the lung tissues dissected at the end of the study. 5-FU caused growth retardation, disturbed the oxidant-antioxidant balance by increasing MDA levels and decreasing GSH levels, triggered cellular apoptosis by increasing Bax and caspase-3 levels and decreasing Bcl-2, also increased lung tissue inflammation and damage by increasing NFκB and IL-1β levels. However, it was determined that Nobiletin prevented the disruption of the oxidant-antioxidant balance, showed significant anti-apoptotic effects, especially by reducing Bax levels and partially modulating caspase-3 and Bcl-2 levels, and also exhibited anti-inflammatory effects by reducing NFκB and IL-1β levels and supported the normal development of animals. Our results showed that nobiletin pretreatment showed anti-inflammatory activity by inhibiting the NFκB pathway in 5-FU-induced lung injury, suppressed oxidative stress with its antioxidant activity and was effective in modulating cellular apoptosis with its anti-apoptotic activity. In conclusion, Nobiletin has been shown to have an important potential in reducing fluorouracil-induced tissue damage by acting through multiple pathways. © The Author(s) 2025.</dc:description><dc:publisher>Springer Science and Business Media Deutschland GmbH</dc:publisher><dc:date>2025</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/10692</dc:identifier><dc:identifier>https://doi.org/10.1007/s00210-024-03773-6</dc:identifier><dc:identifier>0028-1298</dc:identifier><dc:language>en</dc:language><dc:relation>Naunyn-Schmiedeberg's Archives of Pharmacology</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/10692</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>